Table 1. Baseline Participant Characteristics by Race Group and Metabolic Syndrome Status, ARIC 1987-89.
| Blacks (N=3,882) | Whites (N=11,212) | |||||
|---|---|---|---|---|---|---|
| No Metabolic Syndrome | Metabolic Syndrome | P-value | No Metabolic Syndrome | Metabolic Syndrome | P-value | |
| Age, years | 53.0 ± 5.9 | 54.3 ± 5.7 | <0.01 | 53.7 ± 5.7 | 55.4 ± 5.6 | <0.01 |
| Male | 953 (45.2) | 526 (29.7) | <0.01 | 3057 (45.1) | 2237 (50.4) | <0.01 |
| Education | ||||||
| < High school | 788 (37.5) | 816 (46.1) | <0.01 | 948 (14.0) | 975 (22.0) | <0.01 |
| HS to College | 594 (28.2) | 509 (28.8) | 3029 (44.8) | 2055 (46.4) | ||
| Graduate school | 721 (34.3) | 444 (25.1) | 2791 (41.2) | 1401 (31.6) | ||
| Smoking Status | ||||||
| Current | 675 (32.1) | 483 (27.2) | <0.01 | 1710 (25.3) | 1054 (23.8) | <0.01 |
| Former | 516 (24.5) | 416 (23.5) | 2295 (33.9) | 1671 (37.7) | ||
| Never | 913 (43.4) | 873 (49.3) | 2765 (40.8) | 1710 (38.5) | ||
| Smoking, pack-yrs | 12.8 ± 20.1 | 11.7 ± 20.0 | 0.12 | 16.0 ± 20.9 | 19.5 ± 23.9 | <0.01 |
| Drinking Status | ||||||
| Current | 774 (37.0) | 447 (25.5) | <0.01 | 4607 (68.1) | 2630 (59.4) | <0.01 |
| Former | 449 (21.4) | 450 (25.6) | 1056 (15.6) | 888 (20.1) | ||
| Never | 870 (41.6) | 858 (48.9) | 1101 (16.3) | 908 (20.5) | ||
| Alcohol, g/week | 39.6 ± 113.2 | 22.9 ± 73.3 | <0.01 | 46.9 ± 90.8 | 44.1 ± 98.9 | 0.12 |
| Body mass index, kg/m2 | 27.4 ± 5.5 | 32.3 ± 5.9 | <0.01 | 25.2 ± 3.8 | 29.8 ± 4.9 | <0.01 |
| Sports score | ||||||
| 1.0 to 3.0 | 1869 (88.9) | 1599 (90.5) | 0.09 | 4967 (73.5) | 3575 (80.9) | <0.01 |
| >3.0 to 5.0 | 234 (11.1) | 167 (9.5) | 1788 (26.5) | 844 (19.1) | ||
| CHD history | 53 (2.5) | 101 (5.7) | <0.01 | 196 (2.9) | 371 (8.5) | <0.01 |
| HF history | 65 (3.1) | 204 (11.6) | <0.01 | 87 (1.3) | 334 (7.7) | <0.01 |
| Waist circumference, cm | 92.9 ± 13.5 | 106.8 ± 13.8 | <0.01 | 90.8 ± 11.3 | 104.5 ± 12.2 | <0.01 |
| Triglycerides, mg/dL | 87.2 ± 35.3 | 146.6 ± 101.5 | <0.01 | 102.0 ± 46.2 | 194.6 ± 117.3 | <0.01 |
| HDL-c, mg/dL | 61.1 ± 17.5 | 47.8 ± 14.7 | <0.01 | 56.4 ± 16.6 | 41.3 ± 12.3 | <0.01 |
| Anti-lipid meds | 3 (0.1) | 52 (3.0) | <0.01 | 48 (0.7) | 336 (7.6) | <0.01 |
| Systolic BP, mmHg | 125.2 ± 20.9 | 133.4 ± 21.3 | <0.01 | 114.0 ± 15.2 | 125.3 ± 17.4 | <0.01 |
| Diastolic BP, mmHg | 78.8 ± 12.5 | 80.8 ± 11.8 | <0.01 | 69.6 ± 9.4 | 74.5 ± 10.4 | <0.01 |
| Antihypertensive meds | 581 (27.6) | 1114 (62.9) | <0.01 | 813 (12.0) | 2066 (46.6) | <0.01 |
| Glucose, mg/dL | 100.3 ± 30.7 | 139.5 ± 71.1 | <0.01 | 97.6 ± 18.0 | 117.7 ± 43.1 | <0.01 |
| Diabetes | 125 (6.0) | 640 (36.2) | <0.01 | 172 (2.5) | 847 (19.1) | <0.01 |
Values are N(%) for categorical variables and Mean ± SD for continuous variables.